214 related articles for article (PubMed ID: 34146727)
1. Liver injury after mRNA-based SARS-CoV-2 vaccination in a liver transplant recipient.
Dumortier J
Clin Res Hepatol Gastroenterol; 2022 Jan; 46(1):101743. PubMed ID: 34146727
[No Abstract] [Full Text] [Related]
2. Immune Response After a Third Dose of the mRNA-1273 SARS-CoV-2 Vaccine in Liver Transplant Recipients.
Odriozola A; Lamadrid-Perojo P; Cuadrado A; San Segundo D; Del Barrio M; Fortea JI; Puente A; Amigo L; Fernández-Santiago R; Castillo F; Achalandabaso M; Andrés Echeverri J; Rodríguez-Sanjuan JC; López-Hoyos M; Crespo J; Fábrega E
Transplantation; 2022 Jul; 106(7):e341-e342. PubMed ID: 35323163
[No Abstract] [Full Text] [Related]
3. Comparison of mRNA-1273 and BNT162b2 SARS-CoV-2 mRNA Vaccine Immunogenicity in Kidney Transplant Recipients.
Haller MC; Kaiser RA; Langthaler S; Brandstetter C; Apfalter P; Kerschner H; Cejka D
Transpl Int; 2021; 35():10026. PubMed ID: 35185359
[No Abstract] [Full Text] [Related]
4. Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with multiple myeloma.
Greenberg RS; Ruddy JA; Boyarsky BJ; Werbel WA; Garonzik-Wang JM; Segev DL; Imus PH
BMC Cancer; 2021 Dec; 21(1):1354. PubMed ID: 34961488
[TBL] [Abstract][Full Text] [Related]
5. New-onset autoimmune hepatitis following mRNA COVID-19 vaccination in a 36-year-old woman with primary sclerosing cholangitis - should we be more vigilant?
Zhou T; Fronhoffs F; Dold L; Strassburg CP; Weismüller TJ
J Hepatol; 2022 Jan; 76(1):218-220. PubMed ID: 34450237
[No Abstract] [Full Text] [Related]
6. A fourth dose of the mRNA-1273 SARS-CoV-2 vaccine improves serum neutralization against the Delta variant in kidney transplant recipients.
Benotmane I; Bruel T; Planas D; Fafi-Kremer S; Schwartz O; Caillard S
Kidney Int; 2022 May; 101(5):1073-1076. PubMed ID: 35231463
[No Abstract] [Full Text] [Related]
7. Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech).
Korth J; Jahn M; Dorsch O; Anastasiou OE; Sorge-Hädicke B; Eisenberger U; Gäckler A; Dittmer U; Witzke O; Wilde B; Dolff S; Kribben A
Viruses; 2021 Apr; 13(5):. PubMed ID: 33923063
[TBL] [Abstract][Full Text] [Related]
8. Antibody Response and Safety After mRNA-1273 SARS-CoV-2 Vaccination in Peritoneal Dialysis Patients - the Vienna Cohort.
Beilhack G; Monteforte R; Frommlet F; Gaggl M; Strassl R; Vychytil A
Front Immunol; 2021; 12():780594. PubMed ID: 34925359
[TBL] [Abstract][Full Text] [Related]
9. Clinical Factors Associated With Lack of Serological Response to SARS-CoV-2 Messenger RNA Vaccine in Liver Transplantation Recipients.
Cholankeril G; Al-Hillan A; Tarlow B; Abrams D; Jacobs JS; Flores NP; Rana A; Kanwal F; Goss JA
Liver Transpl; 2022 Jan; 28(1):123-126. PubMed ID: 34724328
[No Abstract] [Full Text] [Related]
10. Meta-Analysis of Risk of Myocarditis After Messenger RNA COVID-19 Vaccine.
Wang M; Wen W; Zhou M; Wang C; Feng ZH
Am J Cardiol; 2022 Mar; 167():155-157. PubMed ID: 35063268
[No Abstract] [Full Text] [Related]
11. Liver injury following SARS-CoV-2 vaccination: A multicenter case series.
Shroff H; Satapathy SK; Crawford JM; Todd NJ; VanWagner LB
J Hepatol; 2022 Jan; 76(1):211-214. PubMed ID: 34339763
[No Abstract] [Full Text] [Related]
12. COVID-19 in a kidney transplant recipient after mRNA-based SARS-CoV-2 vaccination.
Tsalouchos A; Rossolini GM; Maggi L; Mazzoni A; Annunziato F; Dattolo PC
Transpl Infect Dis; 2021 Aug; 23(4):e13649. PubMed ID: 34032340
[No Abstract] [Full Text] [Related]
13. Acceptance of SARS-CoV-2 vaccines by liver transplant recipients and candidates.
Reuken PA; Albers S; Rauchfuss F; Strnad P; Settmacher U; Trautwein C; Stallmach A; Bruns T
Z Gastroenterol; 2021 Dec; 59(12):1288-1296. PubMed ID: 34670294
[TBL] [Abstract][Full Text] [Related]
14. Young Male With Myocarditis Following mRNA-1273 Vaccination Against Coronavirus Disease-2019 (COVID-19).
Kaneta K; Yokoi K; Jojima K; Kotooka N; Node K
Circ J; 2022 Mar; 86(4):721. PubMed ID: 34744118
[No Abstract] [Full Text] [Related]
15. Clinical update on the efficacy of anti-SARS-CoV-2 mRNA vaccines in patients on the waiting list for liver transplantation and in liver transplant recipients.
Toniutto P; Aghemo A; Grossi P; Burra P;
Dig Liver Dis; 2021 Oct; 53(10):1232-1234. PubMed ID: 34393073
[No Abstract] [Full Text] [Related]
16. Sars-Cov-2 vaccination in liver transplant recipients: The 'holy grail' in a hostile environment.
Burra P; Russo FP
Liver Int; 2022 Jun; 42(6):1225-1228. PubMed ID: 35678039
[No Abstract] [Full Text] [Related]
17. Analysis of antibody responses after COVID-19 vaccination in liver transplant recipients and those with chronic liver diseases.
Thuluvath PJ; Robarts P; Chauhan M
J Hepatol; 2021 Dec; 75(6):1434-1439. PubMed ID: 34454993
[TBL] [Abstract][Full Text] [Related]
18. Myocarditis after vaccination against covid-19.
Gellad WF
BMJ; 2021 Dec; 375():n3090. PubMed ID: 34916217
[No Abstract] [Full Text] [Related]
19. Weak anti-SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipients.
Benotmane I; Gautier-Vargas G; Cognard N; Olagne J; Heibel F; Braun-Parvez L; Martzloff J; Perrin P; Moulin B; Fafi-Kremer S; Caillard S
Kidney Int; 2021 Jun; 99(6):1487-1489. PubMed ID: 33775674
[No Abstract] [Full Text] [Related]
20. Adjustment of Immunosuppressants to Facilitate Anti-COVID-19 Antibody Production after mRNA Vaccination in Liver Transplant Recipients.
Lee WC; Hung HC; Lee JC; Huang CG; Huang PW; Gu PW; Wang YC; Cheng CH; Wu TH; Lee CF; Wu TJ; Chou HS; Chan KM
Viruses; 2023 Mar; 15(3):. PubMed ID: 36992386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
